• Login
    View Item 
    •   Mak UD Home
    • College of Health Sciences (CHS)
    • School of Medicine (Sch. of Med.)
    • School of Medicine (Sch. of Med.) Collection
    • View Item
    •   Mak UD Home
    • College of Health Sciences (CHS)
    • School of Medicine (Sch. of Med.)
    • School of Medicine (Sch. of Med.) Collection
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Pre-clinical validation and formulation of capsules of abelmoschus esculentus seed extract for weight loss.

    Thumbnail
    View/Open
    NAMULI-CHS-B.PHARM.pdf (2.224Mb)
    Date
    2020-11-30
    Author
    Namuli, Veronica
    Niwandinda, Phionah
    Bitamazire, Ava Airizibwe
    Metadata
    Show full item record
    Abstract
    ABSTRACT Back ground; Abelmoschus esculentus (Okra) is a vegetable that is consumed worldwide and has been studied and found to be rich in phytochemicals like flavonoids, polyphenols etc. Various studies about the plant have proved its medicinal importance in conditions like diabetes mellitus, hyper-lipidemia and obesity among others. Over 315million people are affected by obesity and it’s putting them at a risk of developing chronic conditions like cardiovascular diseases. The current medications e.g. orlistat are associated with high cost and intolerable adverse effects like faecal incontinence. The use of locally available natural agents to curb obesity would be of tremendous benefit Objective: To pre-clinically validate weight loss activity of Abelmoschus esculentus seed extract and formulate capsules of seed extract to aid in weight loss Method: An experimental study design was used in the study. Dry Abelmoschus esculentus seeds were ground and extracted using 70% ethanol. Weight loss activity of the extract was tested in hamster albino rats by first inducing overweight with cheese and then orally administering different doses of the extract for 24 days. Weights were taken every 3 days to assess weight loss. Acute toxicity and histopathological studies done to assess the safety of the extract. From the extract, capsules were formulated and their physical properties, dissolution, uniformity of weight and stability profile were determined using appropriate methods from the British Pharmacopoeia (2009). Results: The extract induced significant weight loss (P value less than 0.05) which was greater than that caused by the positive control orlistat. The acute toxicity and histopathological studies showed no serious effects on the organs (kidneys, liver and heart). The formulated capsules passed the quality control and stability tests. Conclusion: Abelmoschus esculentus seed extract causes weight reduction, is safe for use and can easily be formulated into capsules of acceptable quality to aid in weight loss
    URI
    http://hdl.handle.net/20.500.12281/10535
    Collections
    • School of Medicine (Sch. of Med.) Collection

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of Mak UDCommunities & CollectionsTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy TypeThis CollectionTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy Type

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV